Terms of Service

← Back to Raydian Health

1. About This Agreement

Raydian Health (the "Platform") is a product of Raydian Tech, a sole proprietorship firm registered in India, having its principal place of business in Jaunpur, Uttar Pradesh, India (GSTIN: 09AKTPJ5145J1ZL) — hereinafter referred to as the "Firm" (where such expression shall, unless repugnant to the context, be deemed to include the proprietor and the proprietor's legal heirs, representatives, administrators, and permitted successors and assigns).

These Terms of Service (the "Terms") govern your access to and use of the Platform, including its website at health.raydiantech.com, the admin web application, and any WhatsApp-based services we provide on behalf of subscribing laboratories. By using the Platform you accept these Terms and our Privacy Policy, which together form a single binding agreement.

If you do not agree with any part of these Terms, you must stop using the Platform.

2. Definitions

• "Firm" — Raydian Tech, as described in Section 1.
• "Platform" — The collection of websites, admin applications, APIs, WhatsApp integrations, and supporting infrastructure operated by the Firm under the Raydian Health name.
• "Services" — The cloud-based SaaS capabilities offered through the Platform, as described in Section 3.
• "User" — A diagnostic laboratory, medical clinic, hospital diagnostic unit, or any individual (administrator, staff, technologist) authorised by such an organisation to access the Platform on its behalf.
• "Patient" / "Data Principal" — A natural person whose personal or clinical data is processed through the Platform on behalf of a User.
• "Subscription" — A paid or trial plan under which a User accesses the Services.
• "Third Party" — Any person, organisation, or service other than the Firm and the User.
• "Parties" — The Firm and the User, jointly. Individually each is a "Party".

Headings are provided only for ease of reference and have no legal or contractual effect on the interpretation of these Terms.

3. Description of Services

The Platform offers the following Services to subscribing laboratories and clinics:

• Laboratory Information System (LIS) — Patient registration, case management, sample tracking, test result entry and sign-off, PDF report generation and printing, billing, partner-lab outsourcing co-ordination, and operational dashboards for the laboratory.
• Automated Report Delivery — Upload of finished PDF reports, OCR-based text extraction, AI-generated plain-language summaries (with mandatory medical disclaimers), and delivery to patients over WhatsApp.
• Patient Queue Management — Real-time doctor queues for clinics, WhatsApp-based status notifications to patients, and a public TV display for waiting areas.
• AI Lab Assistant — A natural-language interface that lets authorised laboratory administrators query their own lab's operational data.
• Q&A Chatbot — AI-powered patient Q&A over WhatsApp, grounded in knowledge-base documents the laboratory itself uploads.
• Analytics — Patient value segmentation (RFM), turnaround analytics, referrer scorecards, demand forecasting, revenue leakage detection — shown only to the laboratory whose data is being analysed.
• Referrer / Doctor Promotion — Optional doctor referral messages sent after report delivery, subject to the laboratory's opt-in.

The Firm may add, remove, modify, or rename any Service from time to time. Material changes will be communicated to affected Users by email.

4. Eligibility

The Platform is available to:

• Diagnostic laboratories, pathology centres, medical clinics, and hospital diagnostic units lawfully operating in India
• Individuals aged 18 years or older who are competent to enter into a binding contract under Indian law
• Authorised representatives of the subscribing organisation, acting within the scope of their authority

The User represents and warrants that they have the authority to bind the organisation on whose behalf they register and use the Platform, and that the organisation is operating lawfully in its jurisdiction.

5. Account Registration and Security

• Users must provide accurate, complete, and current information at registration, and keep it updated.
• Each account is for one organisation only. Account credentials must not be shared with personnel outside the organisation or across organisations.
• The User is solely responsible for the confidentiality of credentials issued under their account. Activity logged under a User's credentials is attributed to that User in the audit trail.
• The User must notify the Firm immediately at support@raydiantech.com on any suspected unauthorised access.
• The Firm may suspend or close accounts found to be created with misrepresented credentials.

6. Subscription, Billing, and Refunds

Where the User has subscribed to a paid plan:

• Subscription fees are invoiced in advance, in Indian Rupees (INR), and are exclusive of applicable taxes including GST.
• The current plans, features, and pricing are published within the Platform or communicated separately. The Firm reserves the right to revise pricing with at least 30 days' notice to existing subscribers.
• Subscriptions renew automatically at the end of each billing cycle unless the User cancels before renewal.
• Usage beyond plan limits may result in additional charges, temporary suspension of features, or a requirement to upgrade.

Refund Policy

Subscription fees and usage charges are non-refundable, including for partially-used billing periods, except in the case of a duplicate charge demonstrably caused by a billing-system error. Refund requests must be raised at support@raydiantech.com within 30 days of the disputed charge.

7. Acceptable Use

The User shall use the Platform only for lawful purposes consistent with the operation of a diagnostic laboratory or clinic. Without limiting the foregoing, the User shall not:

• Upload reports or records that are forged, fraudulent, or misleading.
• Send unsolicited promotional messages through the WhatsApp integration, or send messages to recipients with whom the User has no legitimate clinical relationship.
• Use the Q&A chatbot, AI Lab Assistant, or report summaries to substitute for qualified medical advice.
• Attempt to access data of any other laboratory or User on the Platform, or to bypass tenant isolation in any form.
• Reverse-engineer, decompile, disassemble, scrape, or otherwise attempt to derive source code, model weights, or proprietary logic of the Platform.
• Use bots, automated scripts, or non-API programmatic methods to access the Platform outside of the documented API.
• Exceed published API rate limits, perform load testing without prior written consent, or otherwise impair Platform performance for other Users.
• Upload or transmit malicious code, viruses, or any payload designed to disrupt the Platform or other systems.
• Use the Platform, its name, logos, or trademarks to imply endorsement or affiliation without prior written consent.
• Frame, mirror, or commercially redistribute the Platform or any Service.

8. Account Ownership in Multi-Owner Laboratories

Many laboratories in India are owned in partnership or by multiple proprietors. To avoid being drawn into ownership disputes between Users:

• Account ownership rests with the organisation, not with any individual administrator who registered the account.
• The Firm will action a request to transfer or reassign ownership of a laboratory's account only on production of documented authority — for example, a partnership resolution, proof of business ownership, or written consent from all current partners.
• Where ownership of a laboratory is disputed between partners and proof of authority cannot be established, the Firm reserves the right to suspend the account until the dispute is resolved between the User's partners.
• The Firm is not a party to and will not adjudicate ownership disputes between User organisations or their proprietors.

9. Beta and Evolving Features

Some Services are offered as beta, preview, or experimental features. These include, but are not limited to: AI-assisted summaries, the AI Lab Assistant, the Q&A chatbot, RFM segmentation, demand forecasting, next-best-test suggestions, and any feature explicitly marked as "Beta" or "Preview" within the Platform.

• Beta features are provided "as is" and may be changed, suspended, withdrawn, or made paid at the Firm's discretion at any time and without notice.
• The Firm makes no service-level commitment for beta features. The Firm will not be liable to the User or any third party for any loss arising from a beta feature being modified, suspended, or withdrawn.
• Use of a beta feature does not entitle the User to any commercial version of that feature, free of charge or otherwise.

10. Sample, Seed, and Default Content

To accelerate onboarding, the Platform seeds new accounts with default content — for example, an initial test catalogue with default normal ranges, sample knowledge-base documents, default report templates, and placeholder signature/letterhead images.

11. AI Features — No Medical Decisions

The Platform uses automated processing and AI-assisted features at several points in the workflow (see the Privacy Policy for the full list).

No output produced by the Platform's AI features constitutes a medical decision. Final clinical interpretation, diagnosis, treatment, and any decision affecting a patient rests entirely with qualified clinical personnel — the laboratory's pathologist, the referring doctor, or the patient's treating doctor. AI-generated summaries always carry a mandatory disclaimer to consult a doctor. The User agrees that:

• AI features are clinical aids only and must not be presented to patients as substitutes for clinical advice.
• The User remains responsible for clinical sign-off, accuracy of reports, and quality of care.
• The Firm shall not be liable for any clinical decision taken in reliance on AI output, whether by the User, the patient, or any third party.

12. Data Ownership and Intellectual Property

• User data: The User retains full ownership of all data they upload or generate within the Platform — PDFs, patient records, knowledge-base documents, signatures, billing data, and AI outputs derived from the User's data. The Firm processes this data on the User's behalf.
• Platform IP: The Platform itself — including its software, APIs, schema design, AI prompts and pipelines, user interface, copy, brand, logos, and documentation — is the intellectual property of the Firm. All rights are reserved. Nothing in these Terms transfers any IP rights to the User except the limited right to use the Platform under an active Subscription.
• Model training: The Firm does not use User data to train its own AI models. The third-party large-language-model providers the Firm uses operate under their published API data policies; the providers currently configured do not use API request data for model training by default. The Firm relies on these provider defaults rather than enforcing the setting per-request.
• Feedback: Suggestions, feature requests, or feedback the User provides may be incorporated into the Platform without obligation, attribution, or compensation.

13. Privacy and Data Protection

The User's use of the Platform is also governed by the Privacy Policy, which sets out how personal data is collected, used, stored, secured, and retained in compliance with the Digital Personal Data Protection (DPDP) Act, 2023.

As a User:

• The User is the Data Fiduciary for the patient data it brings to the Platform, and the Firm is its delegated processor.
• The User is responsible for obtaining lawful consent from patients (or their guardians, in the case of minors under DPDP §9) before bringing their personal data onto the Platform.
• The User shall co-operate with Data Principal access, correction, and erasure requests in accordance with the DPDP Act.
• For patient access and erasure requests, the User is the primary verification point: the User shall verify the requesting patient's identity in person or against its own visit records, and then raise the request with the Firm from the User's authenticated admin session. The Firm's identity-verification process for requests made directly to it is described in the Privacy Policy.

14. WhatsApp Business Platform Compliance

The Firm's WhatsApp delivery is provided through the Meta WhatsApp Business Cloud API and is subject to Meta's WhatsApp Business and Commerce Policies. The User agrees to:

• Only send messages to patients with whom the User has a legitimate clinical relationship.
• Not use the WhatsApp channel for spam, unrelated promotional content, or content prohibited by Meta's policies.
• Honour patient opt-out / STOP requests promptly.
• Use approved message templates appropriately and avoid sending templated content outside the 24-hour customer-service window unless a valid template applies.

15. Service Availability

The Firm uses commercially reasonable efforts to keep the Platform available and performant. The Platform is provided on a best-effort basis without a formal uptime guarantee. The Firm:

• Schedules maintenance windows and gives advance notice where reasonably practicable.
• Relies on third-party infrastructure providers (cloud hosting, WhatsApp Cloud API, large-language-model providers) whose availability is outside the Firm's direct control.
• Is not liable for downtime, message delivery delays, or service degradation caused by Force Majeure events (see Section 20) or by third-party service failures.

16. Limitation of Liability

• The Firm shall not be liable for any indirect, incidental, special, consequential, exemplary, or punitive damages arising out of or in connection with the User's use of the Platform.
• The Firm's aggregate liability for any claim, regardless of the form of action, shall not exceed the total amount paid by the User to the Firm in the 12 months preceding the event giving rise to the claim.
• The Firm is not liable for any clinical decision made on the basis of AI-generated content, or for the User's failure to validate seed content as required by Section 10.
• The Firm is not liable for failures or delays caused by Meta, cloud providers, large-language-model providers, OCR providers, or any other third-party service the Platform depends on.
• The Firm is not liable for the User's failure to maintain external backups of clinical records that the User is legally required to retain.

17. Indemnification

The User shall indemnify, defend, and hold harmless the Firm, its proprietor, employees, contractors, and affiliates from and against any claim, demand, loss, damage, fine, or expense (including reasonable legal fees) arising out of:

• The User's breach of these Terms or of the Privacy Policy;
• The User's violation of any applicable law, including healthcare, data-protection, or consumer-protection law;
• Any claim by a patient or third party in relation to data the User brought onto the Platform;
• The User's misuse of the Platform, the WhatsApp integration, or any Service.

18. Term and Termination

• By the User: The User may cancel their Subscription at any time. The User's access continues until the end of the current billing cycle; subscription fees already paid are non-refundable except as set out in Section 6.
• By the Firm: The Firm may suspend or terminate the User's access at any time, with or without notice, where the User has breached these Terms, where overdue payments remain unpaid after a 15-day cure period, where continued use poses a security or compliance risk, or where required to do so by law.
• Effect of termination: On termination, the User's right to access the Platform ends. The Firm retains User data for a reasonable transition period (typically 30 days) to allow export, after which data is deleted or anonymised in line with the Privacy Policy. Audit and consent logs are retained indefinitely as required by DPDP §6 and §8(7).
• Survival: Sections that by their nature should survive termination — including 11 (No Medical Decisions), 12 (IP), 16 (Limitation of Liability), 17 (Indemnification), 22 (Governing Law), and 24 (Miscellaneous) — survive termination.

19. Communications Consent

By registering on the Platform and providing contact details, the User consents to receive operational and service-related communications from the Firm — including email, SMS, WhatsApp, and voice calls — concerning account activity, security alerts, billing, maintenance, product updates, and grievance responses. The User may opt out of non-essential marketing communications by writing to support@raydiantech.com; opt-out of essential service communications is not possible while the account remains active.

20. Force Majeure

Neither Party shall be liable for any failure or delay in performance arising from causes beyond its reasonable control, including but not limited to acts of God, natural disasters, pandemics, war, civil unrest, government or regulatory action, internet or telecommunications failures, undersea-cable disruptions, cyber-attacks, denial-of-service events, third-party service outages (cloud providers, WhatsApp, large-language-model providers), or any other event of force majeure. The affected Party shall use reasonable efforts to mitigate the impact and resume performance as soon as practicable.

21. Modifications to These Terms

The Firm may revise these Terms from time to time. Material changes will be communicated to registered laboratory administrators by email at least 30 days before they take effect, except where shorter notice is required by law or operational urgency. The "Last Updated" date at the top of this page indicates when the Terms were last revised. Continued use of the Platform after a revision constitutes acceptance of the revised Terms.

22. Governing Law and Dispute Resolution

• These Terms and any dispute arising in connection with them are governed by the laws of India.
• Before initiating any formal proceeding, the Parties shall attempt to resolve the dispute amicably through good-faith discussions for a period of at least 30 days from written notice of the dispute.
• If amicable resolution fails, the dispute shall be subject to the exclusive jurisdiction of the competent courts at Jaunpur, Uttar Pradesh, India.

23. Grievance Channel

For grievances, complaints, or escalations relating to the Platform or to the processing of personal data, Users and patients may write to:

Raydian Tech
Email: support@raydiantech.com

The Firm acknowledges grievances within 48 hours and provides a substantive response within 30 days of receipt.

24. Miscellaneous

24.1 Severability

If any provision of these Terms is held to be invalid, unlawful, or unenforceable by a court or regulator of competent jurisdiction, that provision shall be modified to the minimum extent necessary to make it enforceable, and the remaining provisions shall continue in full force and effect.

24.2 Waiver

A Party's failure to enforce any provision of these Terms shall not be construed as a waiver of that or any other provision. Any waiver must be in writing to be effective and shall apply only to the specific instance addressed.

24.3 Entire Agreement

These Terms, together with the Privacy Policy and any commercial order form or written subscription agreement entered into between the Parties, constitute the entire agreement between the User and the Firm in relation to the Platform, and supersede all prior or contemporaneous communications, representations, or agreements, whether oral or written, on the same subject.

24.4 Assignment

The User may not assign or transfer these Terms, or any rights or obligations under them, without the prior written consent of the Firm. The Firm may assign these Terms in connection with a merger, acquisition, sale of business assets, or by operation of law, on notice to the User.

25. Contact Us

For questions about these Terms of Service, account-related queries, grievances, or general inquiries:

Raydian Tech
Sole proprietorship firm, Jaunpur, Uttar Pradesh, India
GSTIN: 09AKTPJ5145J1ZL
Email: support@raydiantech.com
General inquiries: info@raydiantech.com
Website: health.raydiantech.com